GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fermenta Biotech Ltd (BOM:506414) » Definitions » E10

Fermenta Biotech (BOM:506414) E10 : ₹11.29 (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Fermenta Biotech E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Fermenta Biotech's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹12.710. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹11.29 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Fermenta Biotech's average E10 Growth Rate was 14.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-04), Fermenta Biotech's current stock price is ₹305.85. Fermenta Biotech's E10 for the quarter that ended in Dec. 2024 was ₹11.29. Fermenta Biotech's Shiller PE Ratio of today is 27.09.

During the past 13 years, the highest Shiller PE Ratio of Fermenta Biotech was 41.40. The lowest was 7.59. And the median was 16.79.


Fermenta Biotech E10 Historical Data

The historical data trend for Fermenta Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fermenta Biotech E10 Chart

Fermenta Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 11.67 10.28 9.39

Fermenta Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.84 9.39 9.31 9.84 11.29

Competitive Comparison of Fermenta Biotech's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Fermenta Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fermenta Biotech's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fermenta Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fermenta Biotech's Shiller PE Ratio falls into.


;
;

Fermenta Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fermenta Biotech's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=12.71/158.3229*158.3229
=12.710

Current CPI (Dec. 2024) = 158.3229.

Fermenta Biotech Quarterly Data

per share eps CPI Adj_EPS
201503 0.828 97.163 1.349
201506 0.469 99.841 0.744
201509 0.078 101.753 0.121
201512 0.118 102.901 0.182
201603 0.828 102.518 1.279
201606 0.751 105.961 1.122
201609 -2.116 105.961 -3.162
201612 -1.581 105.196 -2.379
201703 -0.737 105.196 -1.109
201706 -0.366 107.109 -0.541
201709 1.280 109.021 1.859
201712 6.893 109.404 9.975
201803 6.511 109.786 9.390
201806 5.547 111.317 7.889
201809 11.960 115.142 16.445
201812 9.660 115.142 13.283
201903 13.330 118.202 17.855
201906 4.860 120.880 6.365
201909 11.310 123.175 14.537
201912 3.340 126.235 4.189
202003 1.060 124.705 1.346
202006 4.710 127.000 5.872
202009 5.090 130.118 6.193
202012 3.390 130.889 4.101
202103 2.530 131.771 3.040
202106 3.920 134.084 4.629
202109 1.560 135.847 1.818
202112 -2.790 138.161 -3.197
202203 2.650 138.822 3.022
202206 -0.900 142.347 -1.001
202209 -2.800 144.661 -3.064
202212 -12.660 145.763 -13.751
202303 -1.430 146.865 -1.542
202306 0.640 150.280 0.674
202309 -9.890 151.492 -10.336
202312 3.410 152.924 3.530
202403 -2.400 153.035 -2.483
202406 -2.010 155.789 -2.043
202409 3.940 157.882 3.951
202412 12.710 158.323 12.710

Add all the adjusted EPS together and divide 10 will get our e10.


Fermenta Biotech  (BOM:506414) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Fermenta Biotech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=305.85/11.29
=27.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Fermenta Biotech was 41.40. The lowest was 7.59. And the median was 16.79.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Fermenta Biotech E10 Related Terms

Thank you for viewing the detailed overview of Fermenta Biotech's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Fermenta Biotech Business Description

Traded in Other Exchanges
N/A
Address
Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments that are Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.

Fermenta Biotech Headlines

No Headlines